You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 18, 2024

Litigation Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)


✉ Email this page to a colleague

« Back to Dashboard


CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)

Docket ⤷  Sign Up Date Filed 2017-05-11
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Esther Salas
Jury Demand None Referred To Michael A. Hammer
Parties CELGENE CORPORATION
Patents 10,555,939; 6,045,501; 6,281,230; 6,315,720; 6,476,052; 6,555,554; 6,561,976; 6,561,977; 6,755,784; 6,869,399; 7,119,106; 7,141,018; 7,189,740; 7,393,862; 7,468,363; 7,968,569; 8,198,262; 8,315,886; 8,404,717; 8,530,498; 8,626,531; 8,648,095; 8,673,939; 8,735,428; 8,828,427; 8,927,592; 9,056,120; 9,101,621; 9,101,622; 9,993,467
Attorneys MONVAN HU
Firms Saul Ewing Arnstein & Lehr LLP
Link to Docket External link to docket
Small Molecule Drugs cited in CELGENE CORPORATION v. HETERO LABS LIMITED
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .
Biologic Drugs cited in CELGENE CORPORATION v. HETERO LABS LIMITED

The biologic drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 168 Letter judgment of non-infringement of U.S. Patent No. 8,828,427 B2 (“’427 patent”). At the …judgment of non-infringement of U.S. Patent No. 8,828,427 (“’427 patent”); WHEREAS, on May 11…summary judgment of non-infringement of the ’427 patent (“Joint Letter concerning summary judgment…5 PageID: 4303 non-infringement of the ’427 patent by May 25, 2018 (17-3159 ECF No. 89, Text Order…summary judgment of non-infringement of the ’427 patent, and wish to join in the joint letter to be submitted External link to document
2018-06-04 171 antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/ … United States Patent (10) Patent No.: … (45) Date of Patent: Sep.9,2014 (54)… U.S. PATENT DOCUMENTS Hopatcong, OH … FOREIGN PATENT DOCUMENTS ( *) Notice: Subject to External link to document
2018-08-29 211 Statement Evidence: • U.S. Patent No. 6,045,501 generally, including … • File History of United States Patent No. 6,045,501 …Evidence: • U.S. Patent No. 6,045,501 generally, including … • File History of U.S. Patent No. 6,045,501 at o Claims, Abstract, … • U.S. Patent No. 6,045,501: External link to document
2018-10-05 227 Exhibits 1-15 (Part 1) antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/ …Claims of U.S. Patent Nos. 8,198,262 (“the ’262 patent”), 8,673,939 (“the ’939 patent”), 8,735,4288,735,428 (“the ’428 patent”), and 8,828,427 (“the ’427 patent”) (collectively, “the Patents-in-Suit”). …clients. One of the patents 3 is a formulation patent. It's a very specific…): Patent Asserted Claims ’262 patent [DEFS_POM_ External link to document
2018-10-24 237 antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/ …clients. One of the patents 3 is a formulation patent. It's a very specific… United States Patent (10) Patent No.: …. I'm joined by Kyle Musgrove, patent 5 counsel, Haynes and Boone in Washington…active defendants. The 19 number of patents asserted here are between four and nine External link to document
2018-11-14 250 705 3 9 6,045,501 04/04/00 Elsayed, et al. … PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK…Pleading PATENT OR DATE OF PATENT HOLDER OF PATENT OR TRADEMARK…submission of the attached form related to a patent application or patent. Accordingly, pursuant to the requirements…examine your submission related to a patent application or patent. If you do not furnish the requested External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.